A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Citations
    • ABNT:
      DURBIN, A. P. et al. A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response. Journal of Infectious Diseases, [s. l.], v. 214, n. 6, p. 832–835, 2016. DOI 10.1093/infdis/jiw067. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=rzh&AN=117665870. Acesso em: 13 ago. 2020.
    • AMA:
      Durbin AP, Kirkpatrick BD, Pierce KK, et al. A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response. Journal of Infectious Diseases. 2016;214(6):832-835. doi:10.1093/infdis/jiw067
    • APA:
      Durbin, A. P., Kirkpatrick, B. D., Pierce, K. K., Carmolli, M. P., Tibery, C. M., Grier, P. L., Hynes, N., Opert, K., Jarvis, A. P., Sabundayo, B. P., McElvany, B. D., Sendra, E. A., Larsson, C. J., Jo, M., Lovchik, J. M., Luke, C. J., Walsh, M. C., Fraser, E. A., Subbarao, K., & Whitehead, S. S. (2016). A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response. Journal of Infectious Diseases, 214(6), 832–835. https://doi.org/10.1093/infdis/jiw067
    • Chicago/Turabian: Author-Date:
      Durbin, Anna P., Beth D. Kirkpatrick, Kristen K. Pierce, Marya P. Carmolli, Cecilia M. Tibery, Palmtama L. Grier, Noreen Hynes, et al. 2016. “A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.” Journal of Infectious Diseases 214 (6): 832–35. doi:10.1093/infdis/jiw067.
    • Harvard:
      Durbin, A. P. et al. (2016) ‘A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response’, Journal of Infectious Diseases, 214(6), pp. 832–835. doi: 10.1093/infdis/jiw067.
    • Harvard: Australian:
      Durbin, AP, Kirkpatrick, BD, Pierce, KK, Carmolli, MP, Tibery, CM, Grier, PL, Hynes, N, Opert, K, Jarvis, AP, Sabundayo, BP, McElvany, BD, Sendra, EA, Larsson, CJ, Jo, M, Lovchik, JM, Luke, CJ, Walsh, MC, Fraser, EA, Subbarao, K & Whitehead, SS 2016, ‘A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response’, Journal of Infectious Diseases, vol. 214, no. 6, pp. 832–835, viewed 13 August 2020, .
    • MLA:
      Durbin, Anna P., et al. “A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.” Journal of Infectious Diseases, vol. 214, no. 6, Sept. 2016, pp. 832–835. EBSCOhost, doi:10.1093/infdis/jiw067.
    • Chicago/Turabian: Humanities:
      Durbin, Anna P., Beth D. Kirkpatrick, Kristen K. Pierce, Marya P. Carmolli, Cecilia M. Tibery, Palmtama L. Grier, Noreen Hynes, et al. “A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.” Journal of Infectious Diseases 214, no. 6 (September 15, 2016): 832–35. doi:10.1093/infdis/jiw067.
    • Vancouver/ICMJE:
      Durbin AP, Kirkpatrick BD, Pierce KK, Carmolli MP, Tibery CM, Grier PL, et al. A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response. Journal of Infectious Diseases [Internet]. 2016 Sep 15 [cited 2020 Aug 13];214(6):832–5. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=rzh&AN=117665870